Proceedings of the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2024
-
Welcome to the 12th ICTHIC!
Published: 16 May 20241221PDF: 139 -
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
Published: 29 February 20241194PDF: 187 -
Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?
Published: 16 May 2024950PDF: 95 -
Endothelial cell dysfunction in cancer: a not-so-innocent bystander
Published: 16 May 2024832PDF: 102 -
Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot
Published: 16 May 2024659PDF: 92 -
Cancer-associated ischemic stroke: current knowledge and future directions
Published: 16 May 2024640PDF: 193 -
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review
Published: 16 May 2024393PDF: 128 -
Venous thromboembolism and mortality in patients with hematological malignancies
Published: 16 May 2024245PDF: 104 -
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma
Published: 16 May 2024251PDF: 85 -
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles
Published: 16 May 2024226PDF: 98 -
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
Published: 16 May 2024236PDF: 119 -
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Published: 16 May 2024332PDF: 141 -
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis
Published: 16 May 2024423PDF: 175 -
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy
Published: 16 May 2024218PDF: 123
